Video Latest - ecancer

Cooperating towards control plans in Myanmar

Dr Soe Aung - Myanmar Oncology Society, Yangon, Myanmar

12 Dec 2016

The big debate: Where to spend scarce resources

Dr Lawrence Shulman - University of Pennsylvania, Philadelphia, USA

12 Dec 2016

ASCO and UICC

Dr Lawrence Shulman - University of Pennsylvania, Philadelphia, USA

12 Dec 2016

PD-1 therapy with eribulin for triple negative MBC

Dr Sara Tolaney - Dana–Farber Cancer Institute, Boston, USA

9 Dec 2016

Women experiencing menopause symptoms less likely to adhere to medication

Dr Samuel Smith - University of Leeds, Leeds, UK

9 Dec 2016

Everolimus extends PFS for HR positive, HER2 negative breast cancer

Dr Noah Kornblum - Montefiore Medical Center, New York, USA

9 Dec 2016

TEAM IIb trial results: Adjuvant ibandronate in early breast cancer

Prof Sabine Linn - Netherlands Cancer Institute, Amsterdam, The Netherlands

9 Dec 2016

Neoadjuvant abemaciclib for HR positive, HER negative breast cancer

Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA

8 Dec 2016

TCHP with/out oestrogen for HR/HER positive breast cancer

Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA

8 Dec 2016

Efficacy of veliparib with carboplatin and paclitaxel for BRCA1/2 mutations in metastatic breast cancer

Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA

7 Dec 2016

Extended adjuvant endrocine therapy with letrozole after aromatase inhibition

Dr Terry Mamounas - UF Health Center, Orlando, USA

7 Dec 2016

PrECOG: Added everolimus extends PFS for HR positive, HER2 negative breast cancer

Dr Noah Kornblum - Montefiore Medical Center, New York, USA

7 Dec 2016

Video